When a patient has acute hyperammonemia due to propionic acidemia (PA) or methylmalonic acidemia (MMA)...

It's about time.

CARBAGLU is the first and only FDA-approved medication indicated for the adjunctive treatment of acute hyperammonemia due to PA or MMA.

Be prepared to act quickly to identify and treat acute hyperammonemia due to PA, MMA, or NAGS deficiency, Rapid progression to a hyperammonemic crisis can occur in anyone with these disorders. FDA-approved CARBAGLU, in conjunction with standard of care, can be the key to normalizing acute high plasma ammonia levels.

X
X